The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource

Pediatr Rheumatol Online J. 2023 Jul 13;21(1):70. doi: 10.1186/s12969-023-00839-2.

Abstract

Background: CLUSTER is a UK consortium focussed on precision medicine research in JIA/JIA-Uveitis. As part of this programme, a large-scale JIA data resource was created by harmonizing and pooling existing real-world studies. Here we present challenges and progress towards creation of this unique large JIA dataset.

Methods: Four real-world studies contributed data; two clinical datasets of JIA patients starting first-line methotrexate (MTX) or tumour necrosis factor inhibitors (TNFi) were created. Variables were selected based on a previously developed core dataset, and encrypted NHS numbers were used to identify children contributing similar data across multiple studies.

Results: Of 7013 records (from 5435 individuals), 2882 (1304 individuals) represented the same child across studies. The final datasets contain 2899 (MTX) and 2401 (TNFi) unique patients; 1018 are in both datasets. Missingness ranged from 10 to 60% and was not improved through harmonisation.

Conclusions: Combining data across studies has achieved dataset sizes rarely seen in JIA, invaluable to progressing research. Losing variable specificity and missingness, and their impact on future analyses requires further consideration.

Keywords: Children and young people; Data harmonisation; JIA.

MeSH terms

  • Arthritis, Juvenile* / drug therapy
  • Child
  • Humans
  • Methotrexate / therapeutic use
  • Precision Medicine
  • Tumor Necrosis Factor Inhibitors

Substances

  • Methotrexate
  • Tumor Necrosis Factor Inhibitors